Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, 2023: High-Level Data, Leading Companies, Trial Outcomes, Enrollment Trends, and Latest Developments
January 25, 2024 08:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023" report has been added to ResearchAndMarkets.com's offering. This...
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2024-2034: IPF Industry to Observe Robust Expansion with Emerging Therapies and Increasing Prevalence of Cough-Related IPF
January 25, 2024 07:29 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ...
Dry Powder Inhaler Devices Pipeline Analysis Report 2023: Stages of Development, Regulatory Pathways, Key Companies, Regional Insights
January 24, 2024 04:59 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...
Global Cystic Fibrosis Lung Disease Market Forecasts Promising Growth with Advances in Therapeutics to 2029
January 08, 2024 13:08 ET
|
Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Lung Disease Market: Analysis By Drug Type, Route of Administration, Distribution Channel, By Region, By Country: Market...
PULMOZYME (Dornase Alfa) Drug Insights and Market Forecasts, 2019-2022 and 2023-2032: Focus on 7MM - United States, Germany, France, Italy, Spain, United Kingdom and Japan
December 14, 2023 10:23 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "PULMOZYME Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review 2023
December 14, 2023 05:48 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Omalizumab (Xolair) Biosimilars & Biosuperiors Pipeline Review" report has been added to ResearchAndMarkets.com's offering.This product provides...
Cystic Fibrosis (CF) Therapeutics Global Research Report 2023: Market to Reach $10.11 Billion in 2027 - Long-term Forecast to 2032
November 29, 2023 10:33 ET
|
Research and Markets
Dublin, Nov. 29, 2023 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cystic fibrosis...
Global Sleep Apnea Market Analysis & Forecast to 2023-2033
November 08, 2023 04:08 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Global Sleep Apnea Market Analysis & Forecast to 2023-2033: Market By Product; By End-user; and by Region" report has been added to ...
Tackling Emerging Post-COVID Autoimmune Trends: In-depth CTD-ILD Market Database
October 26, 2023 12:33 ET
|
Research and Markets
Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- In a significant development reported this month in JAMA Network Open, South Korean researchers have pointed out an increased risk of various new-onset...
World Respiratory Collaboration and Licensing Deals Trends Analysis Report and Directory 2023
October 18, 2023 10:08 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Respiratory Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. "Respiratory Collaboration and...